MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/microorganisms14050964

Медицинская библиотека · Microorganisms · 2026

The Use of Bacteria and Their Toxins as Antitumor Agents: Present and Future.

Ibarra-Velázquez Luz María, Cardona-López Marco Antonio, Cervantes-Figueroa Reynaldo Salvador, Ascencio-Navarrate Alba Guadalupe, Becerra-Mercado María Elena, Madriz-Elisondo Ana Luisa

СтатьяОбзорПеревод в очереди

Аннотация

Cancer remains one of the leading causes of morbidity and mortality worldwide, and despite major advances in surgery, chemotherapy, radiotherapy, and immunotherapy, important therapeutic limitations persist, including systemic toxicity, therapeutic resistance, and poor drug penetration into hypoxic tumor regions. These challenges have renewed interest in alternative biological strategies, particularly the use of bacteria and bacterial toxins as antitumor agents. Certain bacterial species possess intrinsic tumor-targeting properties, including the ability to selectively colonize hypoxic and necrotic regions of solid tumors that are poorly accessible to conventional therapies. This review provides a comprehensive analysis of the mechanisms underlying bacteria-mediated anticancer activity, including selective tumor colonization, direct oncolysis, immune activation, and toxin-mediated cytotoxicity. Both obligate anaerobes (e.g., Clostridium and Bifidobacterium) and facultative anaerobes (e.g., Salmonella, Escherichia coli, and Listeria monocytogenes) are examined for their tumor-targeting potential. In addition, we discuss the oncological applications of several bacterial toxins and toxin-derived therapeutic constructs, including Cytolysin A (ClyA), Clostridium difficile toxin B (TcdB), diphtheria toxin, Pseudomonas aeruginosa exotoxin A, and Clostridium perfringens enterotoxin (CPE). Emerging strategies such as recombinant immunotoxins and bacterial-directed enzyme prodrug therapy (BDEPT) are also reviewed. Finally, current translational challenges, including pharmacokinetic limitations, immune clearance, and biosafety considerations, are analyzed, highlighting future directions for integrating bacteria-based platforms into next-generation cancer therapies. This approach reflects the growing interest in microbial strategies for oncology and underscores the potential of bacteria and their toxins as innovative tools in the development of targeted anticancer therapies.

Для цитирования: Ibarra-Velázquez Luz María, Cardona-López Marco Antonio, Cervantes-Figueroa Reynaldo Salvador, Ascencio-Navarrate Alba Guadalupe, Becerra-Mercado María Elena, Madriz-Elisondo Ana Luisa. The Use of Bacteria and Their Toxins as Antitumor Agents: Present and Future.. Microorganisms. 2026. DOI: 10.3390/microorganisms14050964.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.